Your body needs vitamin A each day for healthy vision. Consume vitamin A-rich foods or dietary supplements consistently along ...
These five Dogs of the Dow may be the perfect play for 2026 for growth and income investors wary of volatility and a ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Apply to become a Senior Planet sponsored athlete to motivate ...
A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
Barchart on MSN
What to expect from Amgen's Q4 2025 earnings report
The drug manufacturing giant is expected to announce its fiscal fourth-quarter earnings for 2025 in the near term. Ahead of ...
Check out some of the medications affected by drugmakers raising prices on life-saving medications this year, as well as some ...
The official prescribing information for rosuvastatin (Crestor) includes the following: “... rare postmarketing reports of ...
Zacks Investment Research on MSN
Are you a value investor? This 1 stock could be the perfect pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack or stroke, according to results from a ...
Repatha, first approved in 2015, has been used by more than 6.7 million patients globally. Earlier this year, the FDA broadened its approved use to include adults at increased risk for major adverse ...
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® (evolocumab) achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results